Diagnosis and treatment of mantle cell lymphoma

Diagnosis and treatment of mantle cell lymphoma

Mantle cell lymphoma (MCL) is a relatively rare lymphoma entity accounting for an estimated 3%–6% of all non-Hodgkin’s lymphoma cases. Characterised by both the incurability of indolent lymphomas and the rapid growth of aggressive lymphomas, MCL has a median overall survival of only 4–5 years....

Full description

Bibliographic Details
Main Authors: Felicitas Hitz, Mario Bargetzi, Sergio Cogliatti, Andreas Lohri, Christian Taverna, Christoph Renner, Ulrich Mey
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2013-11-01
Series:Swiss Medical Weekly
Subjects:
autologous stem cell transplant
chemotherapy
first-line treatment
maintenance treatment
mantle cell lymphoma
relapsed/refractory disease
Online Access:https://www.smw.ch/index.php/smw/article/view/1773

Internet

https://www.smw.ch/index.php/smw/article/view/1773

Similar Items